JP2017516501A5 - - Google Patents

Download PDF

Info

Publication number
JP2017516501A5
JP2017516501A5 JP2017515878A JP2017515878A JP2017516501A5 JP 2017516501 A5 JP2017516501 A5 JP 2017516501A5 JP 2017515878 A JP2017515878 A JP 2017515878A JP 2017515878 A JP2017515878 A JP 2017515878A JP 2017516501 A5 JP2017516501 A5 JP 2017516501A5
Authority
JP
Japan
Prior art keywords
hybridization
classifier biomarkers
biomarkers
classifier
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017515878A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017516501A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/033611 external-priority patent/WO2015184461A1/en
Publication of JP2017516501A publication Critical patent/JP2017516501A/ja
Publication of JP2017516501A5 publication Critical patent/JP2017516501A5/ja
Pending legal-status Critical Current

Links

JP2017515878A 2014-05-30 2015-06-01 肺がんのタイピング法 Pending JP2017516501A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462005229P 2014-05-30 2014-05-30
US62/005,229 2014-05-30
PCT/US2015/033611 WO2015184461A1 (en) 2014-05-30 2015-06-01 Methods for typing of lung cancer

Publications (2)

Publication Number Publication Date
JP2017516501A JP2017516501A (ja) 2017-06-22
JP2017516501A5 true JP2017516501A5 (enExample) 2018-07-12

Family

ID=54699976

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017515878A Pending JP2017516501A (ja) 2014-05-30 2015-06-01 肺がんのタイピング法

Country Status (6)

Country Link
US (1) US10829819B2 (enExample)
EP (1) EP3149209B1 (enExample)
JP (1) JP2017516501A (enExample)
CN (1) CN107208131A (enExample)
CA (1) CA2950623A1 (enExample)
WO (1) WO2015184461A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2982775A1 (en) * 2015-04-14 2016-10-20 Genecentric Therapeutics, Inc. Methods for typing of lung cancer
EP3458612B1 (en) 2016-05-17 2023-11-15 Genecentric Therapeutics, Inc. Methods for subtyping of lung adenocarcinoma
CN109863251B (zh) 2016-05-17 2022-11-18 基因中心治疗公司 对肺鳞状细胞癌亚型分型的方法
CA3115922A1 (en) * 2018-10-09 2020-04-16 Genecentric Therapeutics, Inc. Detecting cancer cell of origin
CN112375826B (zh) * 2020-12-03 2021-08-27 远见生物科技(上海)有限公司 一种鉴别非小细胞肺癌亚型的环状rna组合物标志物及其应用
CN113186287B (zh) * 2021-05-10 2023-03-24 深圳康华君泰生物科技有限公司 用于非小细胞肺癌分型的生物标志物及其应用
CN115851927A (zh) * 2022-08-09 2023-03-28 上海善准医疗科技有限公司 肺鳞癌分子分型及生存风险基因群及诊断产品和应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843155A (en) 1987-11-19 1989-06-27 Piotr Chomczynski Product and process for isolating RNA
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
DK0604552T3 (da) 1991-09-18 1997-08-04 Affymax Tech Nv Fremgangsmåde til syntese af forskellige samlinger af oligomerer
US5677195A (en) 1991-11-22 1997-10-14 Affymax Technologies N.V. Combinatorial strategies for polymer synthesis
US5384261A (en) 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US5545531A (en) 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
EP0880598A4 (en) 1996-01-23 2005-02-23 Affymetrix Inc RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM
AU1287799A (en) 1997-10-31 1999-05-24 Affymetrix, Inc. Expression profiles in adult and fetal organs
US6020135A (en) 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
AU2002226912A1 (en) * 2000-11-16 2002-05-27 Cedars-Sinai Medical Center Profiling tumor specific markers for the diagnosis and treatment of neoplastic disease
US7473767B2 (en) 2001-07-03 2009-01-06 The Institute For Systems Biology Methods for detection and quantification of analytes in complex mixtures
AU2002343443A1 (en) * 2001-09-28 2003-04-14 Whitehead Institute For Biomedical Research Classification of lung carcinomas using gene expression analysis
US7955800B2 (en) * 2002-06-25 2011-06-07 Advpharma Inc. Metastasis-associated gene profiling for identification of tumor tissue, subtyping, and prediction of prognosis of patients
US20060024692A1 (en) 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
TW200413725A (en) 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
US8450057B2 (en) * 2006-08-14 2013-05-28 The Brigham And Women's Hospital, Inc. Diagnostic tests using gene expression ratios
WO2008151110A2 (en) 2007-06-01 2008-12-11 The University Of North Carolina At Chapel Hill Molecular diagnosis and typing of lung cancer variants
CN101914542B (zh) * 2009-04-28 2013-03-06 中国科学院化学研究所 用于不同亚型非小细胞肺癌分型的一种核酸适体及其筛选方法
US9914972B2 (en) * 2011-03-28 2018-03-13 Rosetta Genomics Ltd. Methods for lung cancer classification
WO2013172926A1 (en) 2012-05-14 2013-11-21 Yale University Immune biomarkers and assays predictive of clinical response to immunotherapy for cancer
WO2013190090A1 (en) * 2012-06-21 2013-12-27 Philip Morris Products S.A. Gene signatures for classifying and grading lung cancer
CA2982775A1 (en) 2015-04-14 2016-10-20 Genecentric Therapeutics, Inc. Methods for typing of lung cancer
EP3458612B1 (en) 2016-05-17 2023-11-15 Genecentric Therapeutics, Inc. Methods for subtyping of lung adenocarcinoma
CN109863251B (zh) 2016-05-17 2022-11-18 基因中心治疗公司 对肺鳞状细胞癌亚型分型的方法

Similar Documents

Publication Publication Date Title
US9125923B2 (en) Use of MiR-26 family as a predictive marker for hepatocellular carcinoma and responsiveness to therapy
EP2412821B1 (en) AREG as a gene expression marker for colorectal cancer prognosis
US8632980B2 (en) Gene expression markers for prediction of patient response to chemotherapy
JP2020530290A5 (enExample)
US20090258795A1 (en) Gene expression markers for prediction of patient response to chemotherapy
JP2018512160A5 (enExample)
CN105431738B (zh) 胃癌的预后预测模型的建立方法
JP2008510454A5 (enExample)
JP2010530746A5 (enExample)
Maxwell et al. MicroRNAs in endometrial cancers from black and white patients
EP3814533B1 (en) Micro-rna signatures for the prediction of liver dysfunction
CN105765081A (zh) 一种用于预测对采用egfr抑制剂的治疗的响应性的方法
JP2010523134A (ja) Egfr/csf−1/caix発現に基づき非小細胞肺癌の化学療法計画および生存余命を決定する方法
JP2024170603A (ja) 免疫チェックポイント阻害療法からの利益を予測する方法
JP6442169B2 (ja) Cd8+t細胞の活性化状態の判定方法、cd4+t細胞数の増加予測方法、及びcd4+t細胞数の減少予測方法、並びにそれらのためのキット
WO2017060988A1 (ja) 免疫状態の判定方法、cd4+t細胞数の増加予測方法、及びcd4+t細胞数の減少予測方法、並びにそれらのためのキット
CN115851927A (zh) 肺鳞癌分子分型及生存风险基因群及诊断产品和应用